Showing results (7681-7690 of 10,083) with videos related to
Sort By:
Pageof 1,009
Current Pharmaceutical Design|July 2, 2011
The uniqueness of the Trypanosoma cruzi mitochondrion: opportunities to identify new drug target for the treatment of Chagas diseasePaes Lisvane Silva, Brian Suárez Mantilla, Maria Julia Barisón, et al.Current Pharmaceutical Design|August 13, 2011
Fluoroquinolones, the cornerstone of treatment of drug-resistant tuberculosis: a pharmacokinetic and pharmacodynamic approachA D Pranger, J W C Alffenaar, R E AarnoutseCurrent Pharmaceutical Design|August 13, 2011
Drug susceptibility testing for optimizing tuberculosis treatmentSami O Simons, Dick van SoolingenCurrent Pharmaceutical Design|August 25, 2011
Vascular abnormalities in essential hypertensionIsabella Sudano, Susanne Roas, Georg NollCurrent Pharmaceutical Design|August 25, 2011
Susceptibility genes in hypertensionC Armani, N Botto, M G AndreassiCurrent Pharmaceutical Design|August 26, 2011
Clinical update on the use of immuno modulators (antiCD3, GAD, Diapep277, anti-IL1) in type 1 diabetesPaolo Pozzilli, Chiara Guglielmi, Daria Maggi, et al.Current Pharmaceutical Design|August 26, 2011
Stem cell-based immunomodulation in type 1 diabetes: beyond the regenerative approachBiancamaria Longoni, Franco MoscaCurrent Pharmaceutical Design|July 9, 2011
Gas bioengineering using hemoglobin-vesicles for versatile clinical applicationsHiromi Sakai, Shinji Takeoka, Koichi KobayashiCurrent Pharmaceutical Design|July 9, 2011
The possible involvement of glycogen synthase kinase-3 (GSK-3) in diabetes, cancer and central nervous system diseasesS Amar, R H Belmaker, G AgamCurrent Pharmaceutical Design|September 22, 2011
mTOR signaling and metabolic regulation of T cells: new potential therapeutic targets in autoimmune diseasesMarina Pierdominici, Davide Vacirca, Federica Delunardo, et al.Pageof 1,009